V-3

N/A

Report date: 2026/01/09 17:59:32
NME

Base Information

Drug NameV-3
Drug Alias NameV-3
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins modulatorsProteolysis
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPeking University School Of Pharmacy
China Registration ClassN/A

Develop Information

Active CompaniesPeking University School Of Pharmacy
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A